MDCO - The Medicines Company

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Annual

Cash Flow

All numbers in thousands
Breakdown
ttm
12/30/2018
12/30/2017
12/30/2016
Cash flows from operating activities
Net Income
-236,388
-123,156
-708,373
-119,118
Depreciation & amortization
2,670
3,195
21,974
31,042
Deferred income taxes
-
0
-89,895
-23
Stock based compensation
19,359
18,070
31,520
30,987
Change in working capital
-4,274
-43,248
9,113
-15,468
Accounts receivable
-1,236
4,959
9,180
30,144
Inventory
860
2,199
6,511
-15,653
Accounts Payable
-136
-9,514
-17,222
-7,398
Other working capital
-198,336
-261,802
-372,813
-335,485
Other non-cash items
31,928
24,632
-25,675
25,137
Net cash provided by operating activites
-198,336
-261,795
-368,288
-323,309
Cash flows from investing activities
Investments in property, plant and equipment
-
-7
-4,525
-12,176
Acquisitions, net
-
-
-
0
Purchases of investments
-
0
-131,560
-
Sales/Maturities of investments
-
0
131,535
0
Other investing activites
3,272
12,672
-478
-3,656
Net cash used for investing activites
3,272
179,048
-5,028
422,043
Cash flows from financing activities
Debt repayment
-
0
-55,000
-323,225
Common stock issued
173,170
15,608
48,621
33,776
Common stock repurchased
-
-
-
-
Dividends Paid
-
-
-
-
Other financing activites
-5,744
-5,975
-10,690
45,399
Net cash used privided by (used for) financing activities
339,926
172,633
-17,071
70,576
Net change in cash
-
-
-
-
Cash at beginning of period
124,118
156,900
541,835
373,173
Cash at end of period
268,980
245,020
151,359
541,835
Free Cash Flow
Operating Cash Flow
-198,336
-261,795
-368,288
-323,309
Capital Expenditure
-
-7
-4,525
-12,176
Free Cash Flow
-198,336
-261,802
-372,813
-335,485